QT

Quanterix CorpNASDAQ QTRX Stock Report

Last reporting period 30 Jun, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

0.533

Micro

Exchange

XNAS - Nasdaq

QTRX Stock Analysis

QT

Uncovered

Quanterix Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

15/100

Low score

Market cap $B

0.533

Dividend yield

Shares outstanding

37.249 B

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 370 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum and other fluids. Its Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. The firm also provides contract research services for customers through its Accelerator Laboratory. The Accelerator Laboratory provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. The firm has completed over 1,700 projects for approximately 400 customers from all over the world using its Simoa platforms.

View Section: Eyestock Rating